Procedural results and late clinical outcomes after percutaneous interventions using long ( 25 mm) versus short (<20 mm) stents
Ran Kornowski, MD, FACCa,b,
Balram Bhargava, MDa,b,
D. M. Shmuel Fuchs, MDa,b,
Alexandra J. Lansky, MD, FACCa,b,
Lowell F. Satler, MD, FACCa,b,
Augusto D. Pichard, MD, FACCa,b,
Mun K. Hong, MD, FACCa,b,
Kenneth M. Kent, MD, PhD, FACCa,b,
Roxana Mehran, MD, FACCa,b,
Gregg W. Stone, MD, FACCa,b and
Martin B. Leon, MD, FACCa,b
a Cardiac Catheterization Laboratory, The Washington Hospital Center, Washington, DC, USA
b The Cardiovascular Research Foundation, The Washington Hospital Center, Washington, DC, USA
View larger version (14K):
[in a new window]
|
Figure 1 (A) Actuarial event-free survival curves for target lesion revascularization (TLR), (B) or any adverse event (death, Q-wave MI or TLR) for one year following long ( 25 mm) versus short (<20 mm) slotted-tube single vessel stenting.
|
|
View larger version (18K):
[in a new window]
|
Figure 2 Stent-to-lesion length ratio plotted against target lesion (TLR) and target vessel (TVR) revascularization rates.
|
|
|
